Genentech
(https://gene.com) 📸 Data Snapshot: May 30, 2026Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
There is virtually zero semantic drift between the homepage signal and sub-page substance. The homepage meta-description claims ‘Breakthrough science,’ which is immediately supported by the ‘Our Medicines’ page containing a vast portfolio of biologics and oncology treatments. The patient navigation reinforces the primary mission of delivering medicine and support rather than pivoting to unrelated service models. Heading structures are consistent, moving logically from high-level commitment statements to granular financial assistance eligibility criteria.
Semantic Coherence is read from the heading hierarchy first: what each page announces in its H1 and headings, then whether the body actually delivers on it. Below is the structure the engine mapped, followed by the clean text to check for drift between promise and reality.
🏗️ Semantic Structure — heading hierarchy & page identity (the promise the page makes)
HOMEPAGE Genentech (https://gene.com)
Genentech
Breakthrough science. One moment, one day, one person at a time.
NAV_FOOTER Genentech: Patients (https://gene.com/patients/)
Genentech: Patients
Breakthrough science. One moment, one day, one person at a time.
NAV_FOOTER Genentech: Our Medicines (https://gene.com/patients/medicines/)
Genentech: Our Medicines
Find important safety information and patient resources for all of our currently marketed medicines.
NAV_FOOTER Genentech: Patient Support Services (https://gene.com/patients/patient-support-services/)
Genentech: Patient Support Services
Breakthrough science. One moment, one day, one person at a time.
📝 The Narrative — clean text per page (homepage promise vs. sub-page reality)
HOMEPAGE · THIN (https://gene.com) Genentech
[H2] Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.
SUB-PAGE · THIN (https://gene.com/patients/) Genentech: Patients
[H2] Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.
SUB-PAGE (https://gene.com/patients/medicines/) Genentech: Our Medicines
Patients / Our Medicines [H1] Our Medicines & Products Medicines Actemra® (tocilizumab) [IMG: Actemra] Activase® (alteplase) [IMG: Activase] Alecensa® (alectinib) [IMG: Alecensa] Avastin® (bevacizumab) [IMG: Avastin] Cathflo Activase® (alteplase) [IMG: Cathflo Activase] CellCept® (mycophenolate mofetil) [IMG: CellCept] Columvi® (glofitamab-gxbm) [IMG: Columvi] Cotellic® (cobimetinib) [IMG: Cotellic] Enspryng® (satralizumab-mwge) [IMG: Enspryng] Erivedge® (vismodegib) [IMG: Erivedge] Esbriet® (pirfenidone) [IMG: Esbriet] Evrysdi® (risdiplam) [IMG: Evrysdi] Gazyva® (obinutuzumab) [IMG: Gazyva] Hemlibra® (emicizumab-kxwh) [IMG: Hemlibra] Herceptin® (trastuzumab) [IMG: Herceptin] Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk) [IMG: Herceptin Hylecta] Itovebi™ (inavolisib) [IMG: Itovebi] Kadcyla® (ado-trastuzumab emtansine) [IMG: Kadcyla] Lucentis® (ranibizumab injection) [IMG: Lucentis] Lunsumio® (mosunetuzumab-axgb) [IMG: Lunsumio] Lunsumio Velo™ (mosunetuzumab-axgb) Luxturna® (voretigene neparvovec-rzyl) [IMG: Luxturna] Nutropin AQ® ((somatropin) injection for subcutaneous use) [IMG: Nutropin AQ] Ocrevus® (ocrelizumab) [IMG: Ocrevus] Ocrevus Zunovo® (ocrelizumab and hyaluronidase-ocsq) [IMG: Ocrevus Zunovo] Perjeta® (pertuzumab) [IMG: Perjeta] Phesgo® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) [IMG: Phesgo] PiaSky® (crovalimab-akkz) [IMG: PiaSky] Polivy® (polatuzumab vedotin-piiq) [IMG: Polivy] Pulmozyme® (dornase alfa) [IMG: Pulmozyme] Rituxan® (rituximab [Oncology]) [IMG: Rituxan] Rituxan® (rituximab [Immunology]) [IMG: Rituxan] Rituxan Hycela® (rituximab and hyaluronidase human) [IMG: Rituxan Hycela] Rozlytrek® (entrectinib) [IMG: Rozlytrek] Susvimo® (ranibizumab injection) [IMG: Susvimo] Tamiflu® (oseltamivir phosphate) [IMG: Tamiflu] Tecentriq® (atezolizumab) [IMG: Tecentriq] Tecentriq Hybreza™ (atezolizumab and hyaluronidase-tqjs) [IMG: Tecentriq Hybreza] TNKase® (tenecteplase) [IMG: TNKase] Vabysmo® (faricimab-svoa) [IMG: Vabysmo] Venclexta® (venetoclax) [IMG: Venclexta] Xofluza® (baloxavir marboxil) [IMG: Xofluza] Xolair® (omalizumab) [IMG: Xolair] Zelboraf® (vemurafenib) [IMG: Zelboraf] [H2] You Might Also Be Interested In [H3] Patient Resource Center Our patient resource center is dedicated to getting patients and caregivers to the right resources. 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST [H3] Report a side effect You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555 or here. Medicine Information SupportAsk about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call a nurse By calling (800) 821-8590Monday-Friday, 5am-5pm PT. Chat with a nurse Use our online chat feature Monday-Friday, 5am-5pm PT. Email a nurse By filling out this form. Sharps Disposal A guide for dealing with used sharps responsibly. Access to Investigational Medicines We're committed to a fair and impartial evaluation of each request for access to our investigational medicines. Find Open Clinical Trials Search clinicaltrials.gov to find out if a trial exists for a specific medicine for a particular disease. [H1] Access to Medicines Genentech Access Solutions offers coverage support, patient assistance, other useful information.
SUB-PAGE (https://gene.com/patients/patient-support-services/) Genentech: Patient Support Services
Patients / Patient Support Services [H5] If you have health insurance and need help paying for your medicine Find affordability options to help you pay for your Genentech medicine. Financial assistance may be available no matter what type of health insurance you have. Learn more [H5] If you don’t have health insurance coverage or have financial concerns and meet eligibility criteria Learn how the Genentech Patient Foundation may be able to help you get your Genentech medicine at no cost. Learn more [H5] If you need help understanding your health insurance coverage and costs Genentech Access Solutions helps people who are taking a Genentech medicine. We work with your doctor’s office, health insurance plan and/or specialty pharmacy to help you get your medicine. Call (877) GENENTECH/(877) 436-3683 to learn more. [H5] If you want information and resources about a health condition and treatment with a Genentech medicine Receive in-person education, mail for updates and tips about your medicine and answers to your questions about your treatment with Genentech Patient Education and Treatment Resources.* Call (877) GENENTECH/(877) 436-3683 to learn more. *Not all of these programs may be available for your specific medicine. [H3] Caregiver Burnout Brochure Gives an overview about burnout, including what it is, common symptoms, how to identify and prevent it and available resources. Download the brochure: English | Spanish [H1] Enroll in Patient Support Services Learn how to complete the Patient Consent Form. [H1] Understanding Insurance & Coverage Get help understanding your health insurance and learn about what options for coverage are out there.
This page presents a snapshot of public data from Genentech, captured on May 30, 2026, to show how machine logic reads Semantic Coherence signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Genentech: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://gene.com to view the most current version of its content and see directly what this company is about and what it offers.